Please login to the form below

Not currently logged in


This page shows the latest Melinta news and features for those working in and with pharma, biotech and healthcare.

Cubist gets green light from FDA for new antibiotic Sivextro

Cubist gets green light from FDA for new antibiotic Sivextro

2020. Other drugs in development to treat ABSSSIs include Furiex Pharmaceuticals' avarofloxacin (phase III), Melinta Therapeutics' delafloxacin (phase III) and The Medicines Company's oritavancin (filed for approval in the US).

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Melinta names chief medical officer Melinta names chief medical officer

    Sue Cammarata has experience at Shire and Novartis. Dr Sue Cammarata has joined Melinta Therapeutics as chief medical officer as the company advances the progress of its late-stage pipeline. ... At Pharmacia, she worked on the anti-infective Zyvox

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...